2000
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in cardiovascular technologies that save and improve lives, today announced that it has received...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced the enrollment of the first...
Indianapolis, IN and Menlo Park, CA - Two years of clinical data demonstrate that Guidant Corporation''s (NYSE and PCX: GDT) ANCURE(tm) Bifurcated Endograft System is an effective and safe,...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that on October 1, 2000 John C. Jenkins will become Vice President and General Counsel of the company, reporting to...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology industry, commends President Clinton''s Executive Memorandum taking the first step toward...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world-leader in the treatment of cardiovascular disease, announced today that it has agreed with Boston Scientific Corporation on a...
Indianapolis, IN and Santa Clara, CA - Guidant Corporation (NYSE and PCX: GDT), a global leader in the development of technologies for the treatment of carotid artery and peripheral vascular...
MULTI-LINK TETRA Coronary Stent System Receives CE Mark Approval Indianapolis, IN and Santa Clara, CA - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery...
Indianapolis, IN and Santa Clara, CA - Patients suffering from re-occurring blockages in coronary arteries can now look forward to a new technology that has been shown to reduce the recurrence of...
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable medical device systems, today announced the start of PACMAN, a multicenter European...